AnaptysBio (ANAB) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
AnaptysBio, Inc. (ANAB) utilizes an asset-light model by outsourcing antibody production to third-party contractors. The EV/EBITDA multiple reflects the dynamics of this approach, where the 11.23 level captures the current state. Revenues are based on royalties from the GSK partnership, while valuation growth relies on the anticipation of Phase 2b data for dermatology drugs.
anaptysbio.com - analytical breakdowns and key metrics (ANAB)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ANAB - Net Profit|Expected Profit AnaptysBio, Inc.|ANAB - Market Cap to Net Income|Projected Price to Earnings AnaptysBio, Inc.|ANAB - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio AnaptysBio Inc.|ANAB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months AnaptysBio|ANAB - Net earnings per share for the last four quarters|Quarterly EPS earnings growth anaptysbio.com|ANAB - Earnings per share growth in current year|Earnings growth forecast for next year AnaptysBio, Inc.
Initial company analysis:AnaptysBio Corp ANAB
The EV/EBITDA multiple relates the total enterprise value, including net debt, to operating profit, allowing an investor to assess the market revaluation of assets relative to their ability to generate cash flow. An EV/EBITDA valuation analysis for AnaptysBio, Inc. (ANAB) is critical, as in the absence of commercial sales, the company's value is sustained by licensing payments and expectations of FDA regulatory approval for its drugs.
Competitors of AnaptysBio, Inc.
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|EV/EBITDA Multiple Precigen Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|NKTR: Company Value to Operating Income Before Depreciation Ratio|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ZBIO (zenasbio.com)|IMNM: Enterprise Value to EBITDA Ratio|Company Value to EBITDA Gossamer Bio Inc|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEPN - Total Company Value to Operating Income Before Depreciation Ratio|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SVRA|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio Astria Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Bio ENGN|rapt.com (RAPT) - Company Value to EBITDA|JBIO: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ACRS (aclaristx.com)|KYTX: EV/EBITDA Multiple|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Enterprise Value to Operating Income Before Depreciation VTYX (Ventyx Biosciences, Inc)|EV/EBITDA Multiple THTX|Enterprise Value to EBITDA Ratio avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Agenus, Inc. (AGEN)|Climb Bio, Inc. - EV/EBITDA Multiple|ZURA - EV/EBITDA Multiple|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ADAG|IMA (ImageneBio) - EV/EBITDA Multiple|EV/EBITDA Multiple Shattuck Therapeutics|EV/EBITDA Multiple EQ|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CNTB (connectbiopharm.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Value to Operating Income Before Depreciation Ratio|InflaRx GmbH - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|BRNS: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOVX (geovax.com)|EDSA: EV/EBITDA Multiple|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple aimimmuno.com AIM|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple Indaptus Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|EV/EBITDA Multiple Allakos Inc ALLK|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IGMS|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|OCEA: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TCBP|Company Value to EBITDA thirdharmonicbio.com THRD
